FTC Sues to Block Covetrus' $3.5B MWI Animal Health Deal

The FTC and 13 states sued to block Covetrus' $3.5 billion acquisition of MWI Animal Health, the two largest veterinary distributors.

@sharedot

FTC Sues to Block Covetrus' $3.5B MWI Animal Health Deal

By @sharedot · · 6 pages

  • Business
  • Antitrust
  • Veterinary
  • Mergers And Acquisitions

The FTC and 13 states sued to block Covetrus' $3.5 billion acquisition of MWI Animal Health, the two largest veterinary distributors.

The lawsuit and the deal it targets

On November 13, 2026, the Federal Trade Commission filed a lawsuit in the US District Court for the Southern District of New York seeking to block Covetrus' proposed $3.5 billion acquisition of MWI Animal Health from parent company Cencora.

Attorneys general from 13 states — including Arizona, California, New York, Texas, and Ohio — joined the complaint, and the commission voted 2-0 to authorize staff to seek a permanent injunction.

The suit also names Covetrus' private equity owners, Clayton, Dubilier & Rice LLC and TPG Inc. The deal, announced in February 2026, would have given Cencora $1.25 billion in cash, $800 million in preferred equity, and $1.45 billion in common equity, retaining a 34.3% noncontrolling stake.

Why regulators see a price war ending

The FTC argues the two companies are the largest veterinary distributors in the US and each other's closest competitors in two markets: distribution to veterinary clinics and distribution to large corporate accounts.

Both supply pharmaceuticals, vaccines, surgical supplies, and so-called white goods such as gloves, gauze, and syringes.

According to the FTC, the pair have competed aggressively on price — Covetrus matched MWI's pricing through price cuts and rebates in its VetSuite program — while the online comparison platform Vetcove intensified the rivalry by letting clinics use one distributor's pricing to negotiate with the other.

The complaint calls years of this competition an "all-out price war" and contends that specialty distributors, manufacturers, and retailers do not meaningfully constrain the major clinic distributors, making the combined market presumptively unlawful under the 2023 FTC-DOJ merger guidelines.

Covetrus' pushback

Covetrus responded the same day, calling the agency's view of the market "narrow and outdated" and saying it is prepared to defend the transaction in court.

The company argued that 15 years of shifting industry dynamics have given practices more purchasing options than ever: manufacturers selling directly to clinics, national and regional rival distributors, and online veterinary marketplaces that Covetrus said more than 60% of US practices use to order from more than 40 distributors and thousands of manufacturers.

It added that clinics routinely buy the same products from multiple suppliers and that retailers now sell flea and tick treatments, pharmaceuticals, and pet foods directly to pet owners. CEO Ben Wolin had said the combination would make animal health care more affordable and accessible.

Stakes for clinics, pet owners, and the deal's fate

The outcome will shape costs across veterinary care, since the FTC contends reduced competition would drive up prices for clinics and their customers, while Covetrus claims the merger would instead improve practice economics and lower its cost of serving veterinarians.

The deal already weathered months of scrutiny: Cencora received an FTC second request in May 2026, regulators sought information from customers and competitors over the summer, and the companies submitted a proposed remedy package on October 6 that reportedly failed to satisfy regulators.

The case now heads to federal court, where Covetrus will defend the transaction and the FTC will seek a permanent injunction. If the deal is blocked, MWI would remain under Cencora's ownership.

Sources

  1. dvm360.com › FTC sues to block Covetrus' merger with MWI Animal Health
  2. bovinevetonline.com › FTC Sues to Block $3.5 Billion MWI Animal Health-Covetrus Merger

More on Business